2型糖尿病前期临床研究进展

www.yongyao.net　　2009-8-18 9:54:12　　来源：　　责任编辑：

分享到：

参考文献
[ 1 ] 　Klein R, Klein BE,Moss SE, et al. Relationship of hyperglycemia to the long2term incidence and p rogression of diabetic retinopathy[ J ]. Arch InternMed, 1994, 154 (19) : 216922178.
[ 2 ] 　Pan XR,Li GW, Hu YH, et al. Effects of diet and exercise in p reventing N IDDM in peop le with impaired glucose tolerance: The DaQing IGT and Diabetes Study [ J ]. Diabetes Care, 1997, 20 ( 4 ) :5372544.
[ 3 ] 　Lindstrêm J, Ilanne2Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow2up of the Finnish Diabetes Prevention Study [ J ]. Lancet,2006, 368 (9548) : 167321639.
[ 4 ] 　David EL,Laaksonen, Jaana L, Timo AL, et al. PhysicalActivity in the Prevention of Type 2 Diabetes2The Finnish Diabetes Prevention Study[ J ]. Diabetes, 2005, 54 (1) : 1582165.
[ 5 ] 　Barr EL, Zimmet PZ,Welborn TA, et al. Risk of cardiovascular and all2cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes,Obesity, and Lifestyle Study (AusDiab) [ J ]. Circulation,2007, 116 (2) : 1512157.
[ 6 ] 　Healy GN,Dunstan DW, Shaw JE, et al. Beneficial associations of physical activity with 22h but not fasting blood glucose in Australian adults: the AusDiab study[ J ]. Diabetes Care, 2006, 29 ( 12) :259822604.
[ 7 ] 　Corpeleijn E, Feskens EJ, Jansen EH, et al. Lifestyle Intervention and Adipokine Levels in Subjects at High Risk for Type 2 Diabetes: the Study on Lifestyle intervention and Impaired glucose toleranceMaastricht ( SL IM ) [ J ]. Diabetes Care, 2007, 30 ( 12 ) :312523127.
[ 8 ] 　Corpeleijn E, Feskens EJ, Jansen EH, et al. Imp rovements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid p rofile and desaturase activities: the SL IM study[ J ]. Diabetologia. 2006, 49 (10) : 239222401.
[ 9 ] 　Absetz P,Valve R,Oldenburg B, et al. Type 2 diabetes p revention in the“real world”: one2year results of the GOAL Imp lementation Trial[ J ]. Diabetes Care, 2007, 30 (10) : 246522470.
[ 10 ] 　PanagiotakosDB, Tzima N, Pitsavos C, et al. The association between adherence to the Mediterranean diet and fasting indices of glucose homoeostasis: the ATTICA Study [ J ]. J Am Coll Nutr,2007, 26 (1) : 32238.
[ 11 ] 　Ratner RE. The Diabetes Prevention Program Research. An update on the Diabetes Prevention Program [ J ]. Endocr Pract, 2006,12 ( Supp l 1) : 20224.
[ 12 ] 　Ratner R, Goldberg R, Haffner S, et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes p revention p rogram[ J ]. DiabetesCare, 2005, 28 (4) : 8882894.
[ 13 ] 　HermanWH, Hoerger TJ, Brandle M, et al. The cost2effectiveness of lifestyle modification ormetformin in p reventing type 2 diabetes in adults with impaired glucose tolerance [ J ]. Ann Intern Med,2005, 142 (5) : 3232332.
[ 14 ] 　Chiasson JL. Acarbose for the p revention of diabetes, hypertension,and cardiovascular disease in subjectswith impaired glucose tolerance: the Study to Prevent Non2Insulin2Dependent DiabetesMellitus ( STOP2N IDDM) Trial[ J ]. Endocr Pract, 2006, 12 ( Supp l 1) :25230.
[ 15 ] 　Chiasson JL, Josse RG, Comis R, et al. Acarbose for p re2vention of type 2 diabetes melhtus: the STOP2N IDDM randomised trial [ J ].Lancet, 2002, 359 (9323) : 207222077.
[ 16 ] 　The DREAM Trial Investigators. Effect of ramip ril on the incidence of diabetes[ J ]. N Engl J Med, 2006, 355 (15) : 155121562.
[ 17 ] 　Shah V, Pratley RE. The DREAM trial: using ramip ril and rosiglitazone to p revent diabetes[ J ]. CurrDiab Rep, 2007, 7 (1) : 53255.
[ 18 ] 　Buchanan TA, XiangAH, Peters RK, et al. Prevention of pancreatic beta2cell function and p revention of type 2 diabetes by pharmacological treatment of insulin resistance in high risk Hispanic women[ J ]. Diabetes, 2002, 51 (9) : 279622803.
[ 19 ] 　Torgerson JS, Haup tman J,Boldrin MN, et al. XENical in the p revention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the p revention of type 2 diabetes in obese patients [ J ]. Diabetes Care,2004, 27 (1) : 1552161.
[ 20 ] 　Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin2converting2enzyme inhibitor, ramip ril, on cardiovascular events in highrisk patients. The Heart Outcomes Prevention Evaluation Study Investigators[ J ]. N Engl J Med, 2000, 342 (3) : 1452153.
[ 21 ] 　中华中医药学会. 糖尿病中医防治指南[M ]. 北京:中国中医药出版社, 2007: 123.
[ 22 ] 　张志远,仝小林,李爱国. 单纯性肥胖的中医虚实研究[ J ]. 中国临床医学月刊, 2003, 2 (12) : 111221113